Eledon Pharmaceuticals logo

Eledon Pharmaceuticals

ELDN | NASDAQ
Chart Builder DCF Calculator
$1.97
-$0.15 (-6.86%)
At close: Nov 16, 2026, 4:00 PM ET
$2.01
+$0.04 (+2.03%)
After-hours: Nov 16, 2026, 7:30 PM ET
-6.86%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
33.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #699/1021 (Top 68%)

Key Statistics

Market Data

Market Cap $226M
1D Range
1.92 2.22
52W Range
1.39 4.21

Valuation (TTM)

PE -2.49
PB 3.24
EV/EBITDA -2.33

Valuation (NTM)

Forward PE N/A
Forward PEG -0.07
Price Target $5.00
Loading financial charts...

Profile

Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating innovative treatments for individuals battling autoimmune disorders, amyotrophic lateral sclerosis (ALS), ...

Sector Healthcare
Industry Biotechnology
Employees 33
IPO Date Sep 17, 2014
Website eledon.com
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$5.00
Upside
+153.81%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.